Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development

Normal Healthy Embryos Clinical Trial

Official title:

Basic Research. Unveiling Factors That Contribute to Germ Cell Differentiation

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01165918
• Other study ID #: Sor491210CTIL
• Status: Not yet recruiting
• Phase: N/A
• First received: July 6, 2010
• Last updated: July 18, 2010
• Start date: October 2010

Study information

• Verified date: June 2010
• Source: Soroka University Medical Center
• Contact: Eitan Lunenfeld, MD and Prof.
• Phone: - 972-8-6460058
• Email: lunenfld[@]bgumail.bgu.ac.il
• Is FDA regulated: No
• Health authority: Israel:Clalit Health Service
• Study type: Observational

Clinical Trial Summary

The purpose of this study is

1. To generate human embryonic stem cells lines (hESC) lines

2. Study of the factors that contribute to differentiation towards germ cell.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A to 4 Days

Eligibility

Inclusion Criteria:

• any donated embryos

Exclusion Criteria:

• not relevant

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Normal Healthy Embryos

Locations

Country	Name	City	State
Israel	Soroka medical center	Beer Sheva

Sponsors (2)

Lead Sponsor	Collaborator
Soroka University Medical Center	Ben-Gurion University of the Negev

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	New hESC	Donated embryos will be used for derivation of the Es cells	1 year	No
Secondary	Factors that contribute to germ cells differentiation	We shall employ the knowledge from a study of sperm differentiation in mice to instruct the differentiation of ES cells towards germ cells	4 years	No